Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer Benny JohnsonScott Kopetz Review Article 05 September 2020 Pages: 567 - 577
Targeting TAM to Tame Pancreatic Cancer Mitchell S. von ItzsteinMichael C. BurkeMuhammad Shaalan Beg Review Article 29 September 2020 Pages: 579 - 588
Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis Huy Gia VuongThu Quynh NguyenLewis Hassell Systematic Review 31 August 2020 Pages: 589 - 598
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product Dietger NiederwieserCaroline HammDavid Chien Original Research Article Open access 12 October 2020 Pages: 599 - 611
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO) Juan Manuel Sepúlveda-SánchezMiguel Gil-GilEstela Pineda Original Research Article 06 October 2020 Pages: 613 - 622
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G) Naoki IzawaKohei ShitaraTakako Eguchi Nakajima Original Research Article 22 September 2020 Pages: 623 - 633
Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan Motohiro FujiwaraTakeshi YuasaJunji Yonese Original Research Article 10 October 2020 Pages: 635 - 643
Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors Jung Kyu ChoiHeeyeong ChoByoung-San Moon Original Research Article 07 October 2020 Pages: 645 - 657
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features Ignazia TusaGiulia CheloniElisabetta Rovida Original Research Article Open access 11 August 2020 Pages: 659 - 671
Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib Tomas BuchlerMarie KopeckaIgor Richter Short Communication 03 August 2020 Pages: 673 - 679
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia Connie KangHannah A. Blair Adis Drug Evaluation 17 September 2020 Pages: 681 - 689
Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis Roberto IacovelliChiara CiccareseGiuseppe Procopio Correction 28 August 2020 Pages: 691 - 691